Teladoc Financial Statements From 2010 to 2024
| 4LL Stock | EUR 11.34 0.15 1.34% |
Check Teladoc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Teladoc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Teladoc financial statements analysis is a perfect complement when working with Teladoc Valuation or Volatility modules.
Teladoc |
Teladoc Company Shares Outstanding Analysis
Teladoc's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Teladoc Shares Outstanding | 162.84 M |
Most of Teladoc's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Teladoc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Teladoc has 162.84 M of shares currently outstending. This is 9.8% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all Germany stocks is 71.52% higher than that of the company.
Teladoc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Teladoc's current stock value. Our valuation model uses many indicators to compare Teladoc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teladoc competition to find correlations between indicators driving Teladoc's intrinsic value. More Info.Teladoc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teladoc's earnings, one of the primary drivers of an investment's value.About Teladoc Financial Statements
Teladoc stakeholders use historical fundamental indicators, such as Teladoc's revenue or net income, to determine how well the company is positioned to perform in the future. Although Teladoc investors may analyze each financial statement separately, they are all interrelated. For example, changes in Teladoc's assets and liabilities are reflected in the revenues and expenses on Teladoc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Teladoc. Please read more on our technical analysis and fundamental analysis pages.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOC HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3652 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Teladoc Stock
When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out the analysis of Teladoc Correlation against competitors. For more detail on how to invest in Teladoc Stock please use our How to Invest in Teladoc guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.